Fortress Biotech Inc 9.375% Series A Cumulativ (FBIOP)
Fortress Biotech Inc 9.375% Series A Cumulativ (FBIOP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FBIOP | ||||
| Company | Fortress Biotech Inc 9.375% Series A Cumulativ | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 9.35 | ||||
| High | 9.35 | ||||
| Low | 9.16 | ||||
| Latest | 9.20 | ||||
| Change | -0.05 | ||||
| % Change | -0.54% | ||||
| Volume | 9,700 | ||||
| 20-Day Average Volume | 22,330 | ||||
| Previous Close | 9.25 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 8.09 | ||||
| 20-Day Raw Stochastic | 83.95% | ||||
| 20-Day Relative Strength | 67.76 | ||||
| Weighted Alpha | +34.95 | ||||
| Today's Opinion | 56% Buy | ||||
| Previous Opinion | 56% Buy | ||||
| Last Month's Opinion | 72% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.43% since 12/17/25 | ||||
| Low | 8.80 on 12/22/25 | ||||
| High | 9.46 on 12/18/25 | ||||
| 1-Month | |||||
| %Chg | +37.31% since 11/24/25 | ||||
| Low | 6.58 on 11/25/25 | ||||
| High | 9.68 on 12/16/25 | ||||
| 3-Month | |||||
| %Chg | +1.32% since 09/24/25 | ||||
| Low | 6.27 on 11/14/25 | ||||
| High | 9.68 on 12/16/25 | ||||
| 6-Month | |||||
| %Chg | +14.62% since 06/24/25 | ||||
| Low | 6.27 on 11/14/25 | ||||
| High | 9.85 on 09/02/25 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 57,675,000 | ||||
| Annual Net Income | -45,997,000 | ||||
| Last Quarter Sales | 17,631,000 | ||||
| Last Quarter Net Income | 5,850,000 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||